IRVINE, Calif. and LITTLETON, Colo., Aug. 24, 2026 /PRNewswire/ — MobileX, the most customizable wireless service designed to save consumers money, today announced a strategic investment from CONX Corporation (OTC: CNXX) (“CONX”). This investment gives CONX a controlling interest in MobileX and injects new capital to accelerate the company’s next phase of growth. As part of the agreement, EchoStar Founder, CEO, and Chairman, as well as CONX Chairman Charlie Ergen and CONX CEO Jason Kiser will join the MobileX Board of Directors.

The investment will help MobileX expand its AI-powered technology platform, grow distribution, and continue its fight against the one-size-fits-all pricing that has defined the wireless industry for decades.

MobileX was built on a simple idea: customers should pay only for what they actually use. Using artificial intelligence to predict data needs and recommend personalized plans, MobileX has become one of the fastest-growing challengers to the traditional carrier model, offering fully customizable plans starting at $3.88 a month*.

“The opportunity ahead is about more than just wireless costs; it’s about redefining how connectivity is delivered and what consumers should expect,” said Peter Adderton, Founder and CEO of MobileX. “CONX shares this vision, and their investment gives us the capital and resources to build on our progress and compete at a much greater scale.”

The investment will allow MobileX to:

Accelerate customer acquisition and expand its independent dealer and retail footprint;Continue investing in its proprietary AI platform that powers personalized plan recommendations; andExplore new opportunities in global connectivity and AI-enabled wireless services.

MobileX customers can build their own plan, choose an Unlimited option, or let MobileX’s AI recommend a plan based on actual usage, all on one of the fastest 5G networks in America. New customers can get started through the MobileX iOS/Android apps, mymobilex.com, Amazon, Walmart.com, as well as at more than 3,700 Walmart stores and 5,000 independent dealer locations nationwide.

Financial terms of the transaction were not disclosed. For more information on MobileX and Terms and Conditions of Service, including its fair use policy, visit mymobilex.com.

* Prices do not include applicable taxes and government surcharges.

About MobileX
Headquartered in Orange County, California, MobileX is the world’s most customizable mobile carrier, delivering the ultimate in choice and cost control. MobileX is a unique service that uses artificial intelligence to predict how much data customers need, delivering a dramatic reduction in cost while ensuring reliable speed and service. MobileX was founded by Peter Adderton, who also founded both Boost Mobile and Digital Turbine. For more information, please visit mymobilex.com.

About CONX
CONX is a diversified operating entity seeking opportunities to power the next generation of innovators in communications and connectivity. CONX’s mission is to partner with emerging companies with quality management and strong and differentiated business models with the ability to scale quickly.

Press contact:
Illume PR for MobileX
mobilex@illumepr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/mobilex-secures-strategic-investment-from-conx-to-fuel-next-phase-of-growth-302858731.html

SOURCE Mobile X Global, Inc.

MIAMI, Aug. 24, 2026 /PRNewswire/ — BreakBio, the third player in personalized drugs after Moderna and BioNTech and the top private company in the personalized drugs space with advanced cutting-edge technology, is entering the clinic next quarter. BreakBio aims to be not first-in-class but best-in-class. It is designed for both higher efficacy than Moderna or BioNTech and it is also designed to treat more cancer indications than Moderna or BioNTech.

BreakBio is designed for higher efficacy than Moderna’s individualized neoantigen therapy (INT). Higher efficacy because BreakBio is designed to find better targets per patient. It is an AI first biotech company. For every patient, its platform integrates highest quality tumor DNA sequencing, RNA sequencing, mass-spectrometry-based immunopeptidomics (of that patient) with proprietary deep AI analysis to find better targets on that patient’s cancer cells. Better targets means killing more (or all) of the cancer cells.BreakBio is designed to extend personalized drugs to more cancer indications than Moderna. BreakBio achieves this by targeting not just neoantigens (associated with mutations as Moderna and BioNTech do) but it also searches for and finds, in each patient, some of the hundreds of cancer-associated non-mutated proteins such as cancer testis antigens, embryonic antigens, etc. – so BreakBio is designed to also work for low mutational cancers, which means it is designed to work for all solid cancers both high mutational cancers like melanoma and low mutational cancers like colorectal.

About BreakBio:

BreakBio is a new generation of personalized cancer drugs designed to deliver both greater efficacy per patient and treat a broader range of cancers than today’s individualized neoantigen therapy competitor. The company combines mass spectrometry, machine learning, and its proprietary AI platform to design and manufacture individualized peptide-based medicines tailored to each patient’s cancer and combines them with approved cancer therapies to drive deeper and more durable anti-tumor responses.

Unlike approaches focused only on mutation-related neoantigen targets found in high-mutational cancers like melanoma, BreakBio targets neoantigens, but also targets non-mutated antigens (found by its AI platform per patient) in order to broaden the treatment to all solid tumors.

Media Contact:
Kim Nancarrow
COO/CFO
BreakBio Corp.
info@breakbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/breakbio-the-third-player-in-personalized-drugs-enters-the-clinic-302858746.html

SOURCE BreakBio Corp.

Ohio’s growing role in strengthening U.S. energy security, advanced manufacturing, and the domestic nuclear fuel supply chain highlighted by state, federal, and industry leaders

High resolution photos/video of the Governor’s tour are available HERE.

Additional photos and b-roll of the Piketon facility are HERE.

PIKETON, Ohio, Aug. 24, 2026 /PRNewswire/ — Centrus Energy (NYSE: LEU) today welcomed Ohio Governor Mike DeWine, Lt. Governor Jim Tressel, JobsOhio CEO J.P. Nauseef and other state, federal and community leaders to its uranium enrichment facility in Piketon, Ohio, for a discussion on Ohio’s role in rebuilding America’s domestic nuclear fuel supply chain and strengthening U.S. energy and economic security.

In September 2025, Centrus joined with Governor DeWine, Senator Jon Husted, Congressman Dave Taylor and other state and federal leaders to announce the company’s multi-billion-dollar expansion of its uranium enrichment plant in Piketon, which is now underway.

“Ohio has created the conditions for companies like Centrus to make substantial investments and plan for the long term,” said Amir Vexler, President and CEO of Centrus. “As we expand our operations here in Piketon, we are restoring a critical domestic capability, strengthening America’s nuclear fuel supply chain, and creating opportunities for the next generation of Ohioans to build careers in one of our nation’s most strategic industries. We are grateful for Governor DeWine’s leadership and for the partnership of JobsOhio, the U.S. Department of Energy, and the local community as we work together to build America’s energy future.”

Centrus’ expansion is expected to support 1,000 construction jobs in Ohio and 300 new operating jobs while retaining 150 existing jobs at the facility. The investment builds on Ohio’s leadership in advanced manufacturing and workforce development and reflects the collaboration among government, industry and local communities that is helping position the state at the center of efforts to rebuild America’s industrial base and secure its energy future.

About Centrus

Centrus Energy is a trusted American supplier of nuclear fuel and services for the nuclear power industry, helping meet the growing need for clean, affordable, carbon-free energy. Since 1998, the Company has provided its utility customers with more than 1,850 reactor years of fuel, which is equivalent to more than 7 billion tons of coal. With world-class technical and engineering capabilities, Centrus is pioneering production of High-Assay, Low-Enriched Uranium and is leading the effort to restore America’s uranium enrichment capabilities at scale so that we can meet our clean energy, energy security, and national security needs. Find out more at www.centrusenergy.com or follow us on LinkedIn and X.

Forward Looking Statements:

This news release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “will”, “should”, “could”, “would” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions with respect to future events and operational, economic and financial performance.

For Centrus Energy Corp., particular factors that involve uncertainty and could cause our actual future results to differ materially from those expressed in our forward-looking statements and which are, and may be, exacerbated by any worsening of the global business and economic environment include but are not limited to the following: the war in Ukraine and other geopolitical conflicts; our government contracts, including related to changes to the U.S. government’s appropriated funding levels for HALEU and the government’s inability to satisfy its obligations, and our lease to our facility in Piketon, Ohio; whether or when government demand for HALEU or LEU for government or commercial uses will materialize and at what level; the impact and potential extended duration of a supply/demand imbalance in the market for LEU; significant competition from major LEU producers, including foreign competitors, who may be less cost sensitive than we are; limitations on our ability to compete in foreign markets; pricing trends and demand in the uranium and enrichment markets, especially in light of the potential of limited supply and our dependence on others for deliveries of LEU; and our ability to successfully implement our planned expansion projects in Piketon, Ohio and Oak Ridge, Tennessee.

Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. Readers are urged to carefully review and consider the various disclosures made in this news release and in our filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2025, under Part II, Item 1A – “Risk Factors” in our Quarterly report on Form 10-Q for the quarter ended March 31, 2026, under Part II, Item 1A – “Risk Factors” in our Quarterly report on Form 10-Q for the quarter ended June 30, 2026, and our filings with the SEC that attempt to advise interested parties of the risks and factors that may affect our business. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

Contacts:

Media — Dan Leistikow
LeistikowD@centrusenergy.com

Investors — Neal Nagarajan
NagarajanNK@centrusenergy.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/centrus-hosts-governor-dewine-and-jobsohio-at-piketon-uranium-enrichment-facility-302858751.html

SOURCE Centrus Energy Corp.